Clinical Trials Directory

Trials / Completed

CompletedNCT03277118

Quantifying Activity Using Wireless Wearable Technology

Quantifying Activity After Cardiac Surgery Using Wireless Wearable Technology

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Wireless wearable devices (WWD) have been shown to be an effective means to measure patient activity and sleep-wake cycles in the ICU. However, no current studies involving WWD have demonstrated the ability of these devices to measure adverse outcomes, including delirium in critically ill patients. This study is unique because the investigators will implement monitoring with the WWD prior to extubation in the ICU to correctly measure first mobilization, as well as capture quality of sleep and episodes of delirium for the first five postoperative days.

Detailed description

In this single-center non-randomized prospective cohort study, cardiac surgical patients undergoing cardiac surgery with cardiopulmonary bypass will be enrolled consecutively with written informed consent from the time this protocol is approved by the IRB until 100 subjects are enrolled (expected duration of subject enrollment is 12 months). Upon arrival into the ICU, cardiac surgery subjects will have a Fitbit Charge 2 device placed on their wrist and will wear the device until the fifth post-operative day. This device will wirelessly transmit data regarding activity and sleep quality to a smartphone application for the duration of wear. No identifiable patient information will be entered into the smartphone application or transmitted to any external entity.

Conditions

Interventions

TypeNameDescription
DEVICEWireless Wearable DeviceWireless Wearable Device will be placed on the wrist of the patient prior to extubation in the ICU to record patient activity in terms of steps and sleep quality.

Timeline

Start date
2017-04-18
Primary completion
2019-08-18
Completion
2019-08-18
First posted
2017-09-08
Last updated
2019-10-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03277118. Inclusion in this directory is not an endorsement.